Gene writing, the precise insertion of large DNA sequences into the genome, as long represented a major challenge in gene therapy. In a study published on April 22, 2026, in Nature, a research team led by Professors Ying Zhang and Hao Yin at Medical Research Institute of Wuhan University reports the development of QuadPE, a new approach that enables efficient and programmable gene writing.
QuadPE builds on prime editing and employs four prime editing guide RNAs (pegRNAs) to generate two pairs of complementary DNA flaps—one on the target genome and the other on the donor DNA. This design directs precise, targeted DNA insertion with high fidelity. Using this strategy, the authors demonstrate gene-scale insertions ranging from 1.6 to 26 kilobases, achieving efficiencies of up to 40%.
Notably, QuadPE operates independently of the cell cycle and shows robust performance in both dividing and non-dividing cells, including neurons and primary human T cells. The method combines high efficiency with strong specificity, addressing key limitations of existing targeted integration technologies.
By enabling precise and scalable gene insertion across diverse cell types, QuadPE provides a versatile platform with broad potential for therapeutic genome engineering and the treatment of genetic diseases.
Full article link: https://www.nature.com/articles/s41586-026-10395-w
